The $177B supplement market is booming—but oversight hasn’t caught up. Experts share what consumers need to know about safety ...
Vegan diets can increase the risk for several mineral deficiencies. Can you adopt a vegan diet without ever using supplements ...
Supplement patches are blurring the line between wellness and beauty.
Injectable weight loss drugs have seized the spotlight in recent years. A promise of appetite control in a prescription.
Vitamins and supplements have gained popularity in recent years, making it challenging to determine which ones are worth the investment. Learn which vitamins work and which ones to skip.
Dr. Ann Coulter of Pennington Biomedical Research Center recently presented research on a novel nutritional supplement that ...
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street ...
Prosper Junior Bakiny has positions in Eli Lilly, Novo Nordisk, and Viking Therapeutics. The Motley Fool has positions in and ...
Investor's Business Daily on MSN
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions. Is the ...
Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
Viking Therapeutics aims to enter one of today's biggest healthcare growth areas: the weight loss drug market. The company is evaluating an injectable candidate in phase 3 studies and an oral ...
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback